PanaTimes

Sunday, Dec 05, 2021
TV

AstraZeneca Covid antibody injection effective at reducing risk of severe illness or death from the virus, trial says

AstraZeneca Covid antibody injection effective at reducing risk of severe illness or death from the virus, trial says

AstraZeneca has released new data from phase-three trials of its Covid-19 antibody injection, AZD7442, showing it reduces the risk of developing severe illness or death from the coronavirus in vulnerable people.
*Your email address will not be displayed on website
This article does not have any comments yet.
PanaTimes
×